Insider Trading & Ownership of Commodore Capital LP

Location: New York, NY
Summary: The estimated value of insider holdings of Commodore Capital LP is at least $431M dollars as of 12 Jan 2024. Commodore Capital LP is the 10%+ Owner of Ambrx Biopharma Inc. and owns shares of Ambrx Biopharma Cayman, Inc. stock worth about $330M. Commodore Capital LP is the 10%+ Owner of Vera Therapeutics, Inc. and owns shares of Vera Therapeutics, Inc. (VERA) stock worth about $79.2M. Commodore Capital LP is the 10%+ Owner of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $21.9M. Commodore Capital LP is the 10%+ Owner of Satsuma Pharmaceuticals, Inc. and owns shares of Satsuma Pharmaceuticals, Inc. stock worth about $326K.
Signature: /s/ Michael Kramarz, Managing Partner
All Insider Reports: All Insider Reports

Notify me when Commodore Capital LP files a new Insider Trading report.

Ownership of Commodore Capital LP

Symbol	Company	Relationship	Holdings Value	Report Period
AMAM	Ambrx Biopharma Cayman, Inc.	10%+ Owner	$330M	23 Feb 2023
VERA	Vera Therapeutics, Inc.	10%+ Owner	$79.2M	10 Jan 2024
ELVN, IMRA	Enliven Therapeutics, Inc.	10%+ Owner	$21.9M	23 Feb 2023
STSA	Satsuma Pharmaceuticals, Inc.	10%+ Owner	$326K	14 Nov 2022
VTGN	Vistagen Therapeutics, Inc.	10%+ Owner		04 Oct 2023

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.